JP2004500810A - Ｉｌ−６様ポリヌクレオチド、ポリペプチド、および抗体 - Google Patents

Ｉｌ−６様ポリヌクレオチド、ポリペプチド、および抗体 Download PDF

Info

Publication number
JP2004500810A
JP2004500810A JP2001544356A JP2001544356A JP2004500810A JP 2004500810 A JP2004500810 A JP 2004500810A JP 2001544356 A JP2001544356 A JP 2001544356A JP 2001544356 A JP2001544356 A JP 2001544356A JP 2004500810 A JP2004500810 A JP 2004500810A
Authority
JP
Japan
Prior art keywords
polypeptide
sequence
antibody
polynucleotide
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2001544356A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004500810A5 (https=
Inventor
ルーベン，　スティーブン　エム．
シ，　ヤング
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of JP2004500810A publication Critical patent/JP2004500810A/ja
Publication of JP2004500810A5 publication Critical patent/JP2004500810A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • AIDS & HIV (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2001544356A 1999-12-09 2000-12-07 Ｉｌ−６様ポリヌクレオチド、ポリペプチド、および抗体 Withdrawn JP2004500810A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16983899P 1999-12-09 1999-12-09
PCT/US2000/033134 WO2001042484A1 (en) 1999-12-09 2000-12-07 Il-6 like polynucleotide

Publications (2)

Publication Number Publication Date
JP2004500810A true JP2004500810A (ja) 2004-01-15
JP2004500810A5 JP2004500810A5 (https=) 2005-01-06

Family

ID=22617397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001544356A Withdrawn JP2004500810A (ja) 1999-12-09 2000-12-07 Ｉｌ−６様ポリヌクレオチド、ポリペプチド、および抗体

Country Status (6)

Country Link
US (1) US20020037523A1 (https=)
EP (1) EP1244807A1 (https=)
JP (1) JP2004500810A (https=)
AU (1) AU2066301A (https=)
CA (1) CA2392740A1 (https=)
WO (1) WO2001042484A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4007477B2 (ja) * 2000-10-13 2007-11-14 独立行政法人科学技術振興機構 エピトープの免疫原性が増強された人工タンパク質
JP2006516635A (ja) * 2003-01-30 2006-07-06 メディミューン，インコーポレーテッド インテグリンαｖβ３アンタゴニストの使用
KR101193708B1 (ko) * 2003-10-17 2012-10-22 추가이 세이야쿠 가부시키가이샤 중피종 치료제
IL163856A0 (en) * 2004-09-01 2005-12-18 Applied Research Systems Use of IL-6 in vascular complications
PT2485583T (pt) 2009-10-06 2016-09-22 Univ Yale Ratinhos geneticamente modificados e enxerto
MX350385B (es) 2011-02-15 2017-09-04 Regeneron Pharma Ratones de m-csf humanizada.
IN2015DN02032A (https=) 2012-09-07 2015-08-14 Univ Yale
CA2887706C (en) 2012-11-05 2022-08-02 Regeneron Pharmaceuticals Genetically modified non-human animals and methods of use thereof
SG10202002187WA (en) 2014-05-19 2020-04-29 Regeneron Pharma Genetically modified non-human animals expressing human epo
KR102658190B1 (ko) 2015-04-13 2024-04-17 리제너론 파마슈티칼스 인코포레이티드 인간화된 sirpa-il15 녹인 마우스 및 이의 이용 방법
KR102618843B1 (ko) 2016-09-20 2024-01-02 베링거잉겔하임베트메디카게엠베하 신규한 ehv 삽입 부위 orf70

Also Published As

Publication number Publication date
EP1244807A1 (en) 2002-10-02
CA2392740A1 (en) 2001-06-14
AU2066301A (en) 2001-06-18
US20020037523A1 (en) 2002-03-28
WO2001042484A1 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
JP2003517304A (ja) クニッツ型プロテアーゼインヒビターポリヌクレオチド、ポリペプチド、および抗体
JP2003514510A (ja) ヒト膵臓および膵臓癌関連遺伝子配列およびポリペプチド
CA2398255A1 (en) Bcl-2-like polynucleotides, polypeptides, and antibodies
JP2003524413A (ja) プラスミノーゲン様ポリヌクレオチド、ポリペプチド、および抗体
JP2003512819A (ja) Ｂ７様ポリヌクレオチド、ポリペプチドおよび抗体
US20070154474A1 (en) Human Prostate Specific G-Protein Receptor HPRAJ70
JP2003513622A (ja) １９個のヒト分泌タンパク質
JP2003503010A (ja) アポトーシス関連遺伝子
JP2002543777A (ja) セリンプロテアーゼ
JP2003501016A (ja) Ａｄａｍのポリヌクレオチドおよびポリペプチド
JP2003512856A (ja) ウテログロビン様ポリヌクレオチド、ポリペプチド、および抗体
JP2003507036A (ja) レチノイドレセプター相互作用ポリヌクレオチド、ポリペプチド、および抗体
JP2004500034A (ja) カルシウムチャネル輸送ポリヌクレオチド、ペプチドおよび抗体
JP2003508036A (ja) アトラクチン様ポリヌクレオチド、ポリペプチド、および抗体
JP2004500810A (ja) Ｉｌ−６様ポリヌクレオチド、ポリペプチド、および抗体
JP2002537810A (ja) ヒトセルピンタンパク質
JP2003512044A (ja) プロテインチロシンキナーゼレセプターポリヌクレオチド、ポリペプチド、および抗体
JP2003508033A (ja) ＴＲＦ−βレセプターポリヌクレオチド、ポリペプチド、および抗体
JP2004507211A (ja) Ａｄａｍポリヌクレオチド、ポリペプチドおよび抗体
JP2003527076A (ja) 骨形態形成タンパク質
JP2003528586A (ja) ３２個のヒト分泌タンパク質
JP2002543770A (ja) 脱共役タンパク質
JP2003503014A (ja) ７回膜貫通レセプター遺伝子
US20030050466A1 (en) TM4SF polynucleotides, polypeptides, and antibodies
JP2003515325A (ja) ４ジスルフィドコアドメイン含有（ｆｄｃｄ）ポリヌクレオチド、ポリペプチド、および抗体

Legal Events

Date Code Title Description
A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20080304